Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Numira Names Hal Widlansky As New CEO

PR Newswire January 9, 2014

FORMA Therapeutics Announces Advancement of Collaboration with Boehringer Ingelheim for Modulating Protein-Protein Interactions in the Treatment of Cancer

Business Wire January 9, 2014

Fiksu Introduces Retargeting to Drive Engagement Across the Complete App Usage Lifecycle

Marketwired January 9, 2014

Endo Announces Divestiture Of HealthTronics

PR Newswire January 9, 2014

A Unique Collaboration of Life Science Leaders, including the Fight Against Cancer Innovation Trust, MaRS Innovation Ventures Trust and MaRS Phase II Investment Trust, has formed Triphase Accelerator Corporation to be an Oncology Development Accelerator

PR Newswire January 9, 2014

NeoStem's Subsidiary, Progenitor Cell Therapy (PCT), to Provide Process Development and Manufacturing Services to Kite Pharma

Globe Newswire January 9, 2014

Cloud Sherpas Highlighted in IDC MarketScape on Salesforce Implementation Ecosystem

Marketwired January 9, 2014

Avelas Biosciences Closes $6.85 Million in Series B Financing to Advance Real-Time Cancer Visualization Technology to Clinical Proof-of-Concept

PR Newswire January 9, 2014

First Patient in Cohort 4 Receives Infusion of Senesco's Therapeutic Candidate, SNS01-T, For the Treatment of Multiple Myeloma and Non-Hodgkins Lymphoma in Phase 1b/2a Clinical Trial

Business Wire January 9, 2014

Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies

PR Newswire January 9, 2014

Research and Markets: Protopic (Atopic Dermatitis) - Forecast and Market Analysis to 2022

Business Wire January 9, 2014

Fuel Cells Market (PEMFC, MCFC, PAFC, SOFC, DMFC & Others) - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast, 2012 - 2018

PR Newswire January 9, 2014

Athersys, Inc. CEO Gil Van Bokkelen to Be Interviewed on Clear Channel Business Talk Radio DFW 1190AM

Marketwired January 9, 2014

Athersys Announces New Patents in Japan for Stem Cell and Regenerative Medicine Technology

Globe Newswire January 9, 2014

Sunesis Pharmaceuticals Expands Hematology Franchise With Global Licenses to Two Kinase Inhibitor Programs

Globe Newswire January 9, 2014

Spectrum Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference in San Francisco on January 16th

Business Wire January 9, 2014

BerGenBio Presents Data at AACR-ISLAC Conference on the Molecular Origins of Lung Cancer

PR Newswire January 9, 2014

Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies

PR Newswire January 9, 2014

CytomX Therapeutics and ImmunoGen, Inc. Announce Strategic Collaboration to Develop Probody-Drug Conjugates Against Cancer Targets

Business Wire January 9, 2014

bluebird bio Appoints Dr James Mandell to its Board of Directors

Business Wire January 9, 2014